{"id":6005,"date":"2025-03-16T15:58:07","date_gmt":"2025-03-16T12:58:07","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=6005"},"modified":"2025-03-16T15:59:34","modified_gmt":"2025-03-16T12:59:34","slug":"in-a-european-population-based-cohort-study-the-lifetime-risk-of-incident-hfref-was-higher-in-men-while-women-were-at-greater-risk-of-developing-hfpef-moreover-8-modifiable-risk-factors-substantia","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/in-a-european-population-based-cohort-study-the-lifetime-risk-of-incident-hfref-was-higher-in-men-while-women-were-at-greater-risk-of-developing-hfpef-moreover-8-modifiable-risk-factors-substantia\/","title":{"rendered":"In a European population-based cohort study, the lifetime risk of incident HFrEF was higher in men, while women were at greater risk of developing HFpEF"},"content":{"rendered":"
In a European population-based cohort study, the lifetime risk of incident HFrEF was higher in men, while women were at greater risk of developing HFpEF. Moreover, 8 modifiable risk factors substantially contributed to these risks, particularly in women.<\/div>\n
ESC Educational team. Date: March 6, 2025<\/div>\n
<\/div>\n
Key Findings:<\/div>\n
<\/span>1. <\/span>Overall Lifetime Risk of Heart Failure (HF):<\/div>\n
<\/span>\u2022 <\/span>Men: 24.5%<\/div>\n
<\/span>\u2022 <\/span>Women: 23.3%<\/div>\n
<\/span>2. <\/span>Lifetime Risk of Heart Failure with Reduced Ejection Fraction (HFrEF):<\/div>\n
<\/span>\u2022 <\/span>Men: 18.1%<\/div>\n
<\/span>\u2022 <\/span>Women: 11.9%<\/div>\n
<\/span>3. <\/span>Lifetime Risk of Heart Failure with Preserved Ejection Fraction (HFpEF):<\/div>\n
<\/span>\u2022 <\/span>Men: 6.4%<\/div>\n
<\/span>\u2022 <\/span>Women: 11.5%<\/div>\n
<\/span>4. <\/span>Contributing Modifiable Risk Factors:<\/div>\n
<\/span>\u2022 <\/span>Eight risk factors were analyzed: hypertension, hypercholesterolemia, obesity, smoking, atrial fibrillation, chronic kidney disease, myocardial infarction, and diabetes mellitus.<\/div>\n
<\/span>5. <\/span>Cumulative Population Attributable Fraction (PAF) for HFrEF:<\/div>\n
<\/span>\u2022 <\/span>Men: 60%<\/div>\n
<\/span>\u2022 <\/span>Women: 71%<\/div>\n
<\/span>6. <\/span>Cumulative PAF for HFpEF:<\/div>\n
<\/span>\u2022 <\/span>Men: 46%<\/div>\n
<\/span>\u2022 <\/span>Women: 64%<\/div>\n
<\/span>7. <\/span>Strongest Risk Factors for HFrEF:<\/div>\n
<\/span>\u2022 <\/span>Men: Hypertension (23%), hypercholesterolemia (20%), myocardial infarction (18%), smoking (16%), obesity (10%)<\/div>\n
<\/span>\u2022 <\/span>Women: Hypertension (39%), hypercholesterolemia (28%), smoking (19%)<\/div>\n
<\/span>8. <\/span>Strongest Risk Factors for HFpEF:<\/div>\n
<\/span>\u2022 <\/span>Men: Hypertension (30%), obesity (16%), diabetes (10%)<\/div>\n
<\/span>\u2022 <\/span>Women: Hypertension (46%), obesity (20%), smoking (12%)<\/div>\n
<\/div>\n
These findings highlight the importance of proactive screening and management of modifiable risk factors, especially in women, to reduce the incidence of heart failure.<\/div>\n
https:\/\/pace-cme.org\/news\/sex-specific-lifetime-risks-of-hfpef-and-hfref-in-europe\/2471486\/.<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

In a European population-based cohort study, the lifetime risk of incident HFrEF was higher in men, while women were at greater risk of developing HFpEF. Moreover, 8 modifiable risk factors substantially contributed to these risks, particularly in women. ESC Educational team. Date: March 6, 2025 Key Findings: 1. Overall Lifetime Risk of Heart Failure (HF): […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6005","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=6005"}],"version-history":[{"count":3,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6005\/revisions"}],"predecessor-version":[{"id":6009,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6005\/revisions\/6009"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=6005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=6005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=6005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}